Is the Ebola virus a real threat for Europe and the US?

Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus.

ELISA and nucleic acid tests enable early detection of Ebola virus. Foto:...
ELISA and nucleic acid tests enable early detection of Ebola virus. Foto: Jeffrey M. Vinocur; Multi-license with GFDL and Creative Commons CC-BY 2.5
ELISA and nucleic acid tests enable early detection of Ebola virus. Foto:...
ELISA and nucleic acid tests enable early detection of Ebola virus. Foto: Jeffrey M. Vinocur; Multi-license with GFDL and Creative Commons CC-BY 2.5

“The Zaire Ebola virus causes a highly contagious and lethal hemorrhagic fever leading to the death of the infected individuals. The recent outbreak of the virus in West Africa has alarmed the world, especially Europe and the US, owing to the geographical speed of the infection spread and high fatality rates. While many experts feel that the chances of the spread of the virus are very low in Europe and the US, healthcare authorities have been on a high alert. As a result, airport security and hospitals have been aggressively preparing for checks of the disease spread.

In view of the high fatality rates caused by the Zaire Ebola virus, it has become increasingly important for healthcare authorities to adopt rapid and robust detection kits. Adoption of ELISA tests and RT-PCR sensitive tests will ensure faster detection of the virus and enable early administration of the therapy.
Hence, a fast and scalable supply of the ELISA and nucleic acid tests is needed to enable early detection. Further in the future, the spread of the virus, similar to that of influenza, should enable pharmaceutical markets to develop anti-Ebola viral therapies or perhaps even vaccines.”
 

05.08.2014

Read all latest stories

Related articles

Photo

Article • testing Ebola

New mobile lab case sees action in Guinea

Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The…

Photo

Article • Treating Ebola

An isolation unit flying on 60-metre wings

The ‘Robert Koch’ plane for medical evacuations (MedEvac) is the winged equivalent of a German hospital isolation ward. Within it, medics with viral haemorrhagic fever while working on the Ebola…

Photo

News • "COMPASS" method

Using nanoparticles for more sensitive rapid tests

A newly developed rapid test needs only a few seconds to reliably detect pathogens such as SARS-CoV-2. It is based on specially designed magnetic nanoparticles.

Related products

Sarstedt - COVID-19 virus diagnostics products

Saliva Collection

Sarstedt - COVID-19 virus diagnostics products

SARSTEDT AG & CO. KG
Siemens Healthineers – Fast Track Real-time PCR assays

Infectious Disease

Siemens Healthineers – Fast Track Real-time PCR assays

Siemens Healthcare GmbH
Arietta 650 DeepInsight

Ultrasound

Fujifilm · Arietta 650 DeepInsight

FUJIFILM Europe GmbH
iQ-View

Reading

Image Information Systems · iQ-View

IMAGE Information Systems Europe GmbH
Nova Biomedical – StatStrip Glucose/Ketone*

Blood Glucose

Nova Biomedical – StatStrip Glucose/Ketone*

Nova Biomedical Corporation
Subscribe to Newsletter